DA32 Life Science Tech Acquisition Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net income was USD 0.385802 million compared to net loss of USD 0.271476 million a year ago.
For the nine months, net loss was USD 0.384859 million.